Precision Medicine Partnering Between Roche and GE Healthcare Drive Breakthroughs for Oncology Drugs
The precision medicine partnering market is expected to demonstrate ample growth with persistent investments towards development and commercialization of customized medicines targeting specific patient groups, influenced by unique factors such as genes, environmental conditions, and lifestyle.
View full press release